BSTC Financial Facts

Diluted net income (loss) per share: 0.35
Total Other income (expense): 77.16K
See Full Income Statement

Deferred tax assets -long term: 3.36M
Income tax receivable: 884.44K
See Full Balance Sheet

BioSpecifics Technologies Corp. (BSTC) Earnings

  |   Expand Research on BSTC
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -0.2% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +0.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/14/16 Q416 $0.36N/A N/A $6.1M$4.6M N/A Details
8/9/16 Q216 $0.37$0.35 +$0.02$6.2M$6.25M N/A Details
5/10/16 Q116 $0.40$0.37 +$0.03$6.6M$6.25M N/A Details
11/9/15 Q315 $0.39N/A N/A $6.3M$7.51M N/A Details
8/10/15 Q215 $0.24N/A N/A $4.7M$2.6M N/A Details
5/11/15 Q414 $0.32N/A N/A $5.6M$2.3M N/A Details
11/10/14 Q314 $0.21$0.19 +$0.02$4M$4M N/A Details
8/11/14 Q214 $0.09$0.12 -$0.03$2.7M$2.91M N/A Details